- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03581864
Clinical Outcomes of Implantationof Black Diaphragm Intraocular Lens in Complete Aniridia and Aphakia Due to Posttraumatic Eye Rupture
Purpose: To assess long-term outcomes of implantation of black diaphragmintraocular lens (BD IOL) in postraumatic aniridia and aphakia due to eye rupture.
METHODS: This is retrospective consecutive case series of 14 eyes with post-traumatic complete aniridia and aphakia treated withscleral fixation of BD IOL with. Measurements included ophthalmological comorbidities, best corrected visual acuity (BCVA), complications, and postoperative interventions. The average postoperative follow-up period was 36 months.
Study Overview
Status
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Lublin, Poland, 20-001
- General Department of Ophthalmology in Lublin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
post-traumatic complete aniridia and aphakia
Exclusion Criteria:
active ocluar inflammation or infection
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Group of 14 patients with post-traumatic complete anirirdia
14 eyes with post-traumatic complete aniridia and aphakia treated withscleral fixation of BD IOL with measurements included ophthalmological comorbidities, best corrected visual acuity (BCVA), complications, and postoperative interventions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Best-corrected visual acuity
Time Frame: 10 to 120 months
|
The visual acuity measurement with ETDRS chart
|
10 to 120 months
|
The slit lamp examination
Time Frame: 10 to 120 months
|
The anterior segment of the eye and eye fundus were examined.
|
10 to 120 months
|
The intrraocular pressure measurement
Time Frame: 10 to 120 months
|
The procedure was performed with the Goldman applanation tonometer.
|
10 to 120 months
|
The medical history
Time Frame: 10 to 120 months
|
Coexisting eye diseases and post-operative complications were noted.
|
10 to 120 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aniridia
-
Clinical Research Consultants, Inc.HumanOptics AGRecruitingFull Aniridia | Partial AniridiaUnited States
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
University of MinnesotaRecruiting
-
Fondation Ophtalmologique Adolphe de RothschildRecruiting
-
PTC TherapeuticsCompletedAniridiaUnited States, Canada
-
University Hospital, MontpellierRecruiting
-
University College, LondonMedical Research Council; Moorfields Eye Hospital NHS Foundation TrustRecruiting
-
PTC TherapeuticsWithdrawn
-
National Eye Institute (NEI)Completed